Viewing Study NCT07386002


Ignite Creation Date: 2026-03-26 @ 3:20 PM
Ignite Modification Date: 2026-03-31 @ 12:25 PM
Study NCT ID: NCT07386002
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-02-10
First Post: 2026-01-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The GLIOMAX Study: MT027 Allogeneic CAR-T for Recurrent Glioma
Sponsor: T-MAXIMUM Pharmaceutical Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module